Literature DB >> 8157447

Maternal immunization to prevent infectious diseases in the neonate or infant.

R A Insel1, M Amstey, K Woodin, M Pichichero.   

Abstract

The approach of providing passive protection to young infants by immunizing pregnant women can bypass the problems of immunological immaturity in the neonate, avoid or delay active immunization of the infant in the first year of life, and prevent transmission of an infection from the mother to the neonate. Optimal vaccines for this approach should induce high immunoglobulin G antibody titers that quickly reach their maximum level after immunization and persist at protective levels for several years, thus providing passive protection in subsequent pregnancies. Specific applications of this approach include the worldwide practice of maternal immunization with tetanus toxoid vaccine and ongoing studies of maternal immunization to prevent Haemophilus influenzae type b, group B streptococcal, pneumococcal, meningococcal, and human immunodeficiency virus infection in the infant. Addressing the cultural, sociological, and legal aspects of maternal immunization will be required to ensure the success of this approach.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157447     DOI: 10.1017/s0266462300014069

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  4 in total

Review 1.  Vaccines for tomorrow.

Authors:  S K Sood
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

2.  Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media.

Authors:  Kathleen A Daly; G Scott Giebink; Bruce R Lindgren; JoAnn Knox; Betty Jo Haggerty; James Nordin; Sarah Goetz; Patricia Ferrieri
Journal:  Vaccine       Date:  2014-10-30       Impact factor: 3.641

3.  Protection of Piglets with Maternally Derived Antibodies from Sows Inoculated with an Attenuated Live Marker Classical Swine Fever Vaccine (Flc-LOM-BErns).

Authors:  SeEun Choe; Jihye Shin; Ki-Sun Kim; Sok Song; Ra Mi Cha; Byung-Il Jung; Bang-Hun Hyun; Bong-Kyun Park; Dong-Jun An
Journal:  Pathogens       Date:  2020-07-27

4.  Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody.

Authors:  Jianjun Chen; Fenghua Zhang; Fang Fang; Haiyan Chang; Ze Chen
Journal:  BMC Infect Dis       Date:  2007-10-16       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.